Skip to main content

Spectrum: Autism Research News

Author

Shaena Montanari

Enterprise Reporter

Shaena Montanari joined Spectrum as an enterprise reporter in January 2023. She was previously an investigative health reporter at the Arizona Center for Investigative Reporting in Phoenix. Shaena holds an M.A. in investigative journalism from Arizona State University’s Walter Cronkite School of Journalism and Mass Communication. Prior to becoming a journalist, Shaena worked as a paleontologist and earned her B.S. in geological sciences at the University of North Carolina at Chapel Hill and her Ph.D. in comparative biology at the Richard Gilder Graduate School at the American Museum of Natural History.

Contact Info

[email protected]

May 2023
Collage of multiple figures on a hillside looking at a large blue book in the distance.

Debate remains over changes in DSM-5 a decade on

by  /  31 May 2023

Changes to the DSM-5’s diagnostic criteria for autism were meant to add clarity, but they also generated new questions.

Comments
April 2023
Image of allegedly duplicated data in a scientific paper.

Questions arise around two published studies from Harvard group

by  /  20 April 2023

An anonymous tipster has been sifting through the papers of Jia Liu and his team.

Comments
March 2023
Drop of liquid medicine with air bubbles is dripping from a pipette on a light pink background.

FDA approval of trofinetide may spur further drug development for Rett

by  /  16 March 2023

The drug, welcomed by patients, might be just the first of many.

Comments
Illustration of a gloved hand reaching down to place a pill bottle on a pedestal.

Debut drug for Rett syndrome at edge of approval

by  /  2 March 2023

The U.S. Food and Drug Administration plans to make an approval decision on the first-ever drug for girls and women with Rett syndrome by 12 March.

Comments
February 2023
Headshot of Johnny Matson, former editor-in-chief of Research in Developmental Disabilities and Research in Autism Spectrum Disorders.

Prolific autism researcher has two dozen papers retracted

by  /  2 February 2023

Elsevier’s retractions focus on peer review and conflicts of interest.

Comments